Select Page

Home / Share Price Target / Sunpharma

Sun Pharma Share Price Target 2024, 2025, 2026 to 2040 With Charts

Sun Pharmaceutical Industries Limited

Company LogoSymbol: SUNPHARMA
Price: ₹1,801.05
Exchange: NSE
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

Sun Pharma Brief Company Overview

Sun Pharmaceutical Industries Limited: A Pharmaceutical Powerhouse

Sun Pharmaceutical Industries Limited is a renowned generic pharmaceutical company with a global reach. Established in 1983, the company has become a leading provider of branded and generic formulations, as well as active pharmaceutical ingredients (APIs).

Sun Pharma's product portfolio covers a wide spectrum of therapeutic areas, including cardiology, neuropsychiatry, oncology, gastroenterology, and many more. The company also offers speciality medications, anti retro viral medications, and over-the-counter products.

With a commitment to innovation and customer satisfaction, Sun Pharma has earned a strong reputation in the industry. Its diverse product range, global presence, and unwavering commitment to quality have made it a trusted partner for healthcare professionals and patients alike.


Sun Pharma Financial Performance

MetricValueDescription
Market Capital3,67,433.4 CroreMarket valuation of Sun Pharma's shares.
Revenue (TTM)47,444.62 CroreTotal revenue generated by Sun Pharma over the past twelve months.
Net Income (TTM)+8,906.27 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin22.05%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin18.77%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+10.1%Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+16.5%Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
3.05Company's total debt divided by total shareholder equity.
Total Debt1,928.23 CroreSum of Sun Pharma's current & long-term financial obligations.
Total Cash14,833.24 CroreTotal amount of liquid funds available to Sun Pharma.
Beta0.52Beta is less than 1 indicating that the Sun Pharma's price is less volatile than the market.

Is Sun Pharma A Good Buy For Long Term?

Sun Pharma, a large-cap stock with consistent revenue growth (9.6% QoQ) and profitability (33.8% YoY earnings growth), appears to be a promising investment for the long term. Its healthy profit margin (19.74%) and strong financial position with ample cash reserves of 19,105.22 Crore indicate the company's financial strength. While it does have some debt (3,273.67 Crore), its strong cash position mitigates any concerns. Overall, the company's impressive financial performance, coupled with its strong fundamentals, make it a suitable choice for long-term investors seeking steady growth and potential returns.

To predict the Sun Pharma's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Sun Pharma Share Price Target For 2024

Sun Pharma Targets For 2024 Chart

The line chart displays the monthly closing prices of Sun Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Sun Pharma shares in 2024, see the table below.

Sun Pharma Share Price Target Table For 2024

Sun Pharma's LevelsValueReason/Importance
2024 Target 31816.8 (+0.87%)Price Action: 13 Dec 2024 High
2024 Target 21814.9 (+0.76%)Price Action: 08 Nov 2024 High
2024 Target 11812.14 (+0.61%)Technical Indicator: MA100
Current Price1801.05Sun Pharma's 1 share price as of Wed 18 Dec 2024
Stop Loss 11875.66 (+4.14%)Fibonacci Retracement Level 23.599999999999998%
Stop Loss 21846.56 (+2.52%)Fibonacci Retracement Level 38.2%
Stop Loss 31823.05 (+1.22%)Fibonacci Retracement Level 50.0%

Summary: Sun Pharma Share Price Prediction For 2024

In summary, Sun Pharma has surged by ₹541.60, achieving a notable +43.00% increase from 1st January 2024 to 18 Dec 2024. Our analysis of Sun Pharma for 2024 predicts an additional rise of 0.61% to 0.87% by the end of 2024 with three potential targets T1: 1812.14, T2: 1814.9, T3: 1816.8. Stop Loss at SL1: 1875.66, SL2: 1846.56, SL3: 1823.05.

Sun Pharma has a 52-week high of ₹1960.35, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1208.55, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Sun Pharma.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Sun Pharma Share Price Target For 2025

Sun Pharma Targets For 2025 Chart

The line chart displays the monthly closing prices of Sun Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Sun Pharma shares in 2025, see the table below.

Sun Pharma Share Price Target Table For 2025

Sun Pharma's LevelsValueReason/Importance
2025 Target 32363.86 (+31.24%)Price Action: Chart
2025 Target 22319.78 (+28.8%)Fibonacci Extension Level 150%
2025 Target 12267.6 (+25.9%)Fibonacci Extension Level 64.9%
Current Price1801.05Sun Pharma's 1 share price as of Wed 18 Dec 2024
Stop Loss 11685.73 (-6.41%)Fibonacci Retracement Level 38.2%
Stop Loss 21668.87 (-7.34%)Price Action: Chart
Stop Loss 31633.66 (-9.3%)Price Action: Apr 2024 High

Summary: Sun Pharma Share Price Prediction For 2025

In summary, Sun Pharma has surged by ₹541.60, achieving a notable +43.00% increase from 1st January 2024 to 18 Dec 2024. Our analysis of Sun Pharma for 2025 predicts an additional rise of 25.9% to 31.24% by the end of 2025 with three potential targets T1: 2267.6, T2: 2319.78, T3: 2363.86. Stop Loss at SL1: 1685.73, SL2: 1668.87, SL3: 1633.66.

Sun Pharma has a All-Time high of ₹1959.30, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1208.55, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sun Pharma, we have created a specific page for that check here: Sun Pharma Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Sun Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2040

Sun Pharma Targets Chart 2024, 2025, 2026 to 2040

This chart presents a detailed projection of Sun Pharma share price predictions from 2024, 2025, 2026 to 2040. This share price Prediction represents a CAGR of 10.81% over the next 15 years.

For complete year by year Sun Pharma long term share price target from 2024, 2025 to 2040 check the below table.

Sun Pharma Share Price Target Table From 2024, 2025, 2026 to 2040

YearSun Pharma TargetYoY Change %
2024₹1,801.05[Current Price]
2024₹2,001.3311.12%
2025₹2,429.9821.41%
2026₹2,644.378.82%
2027₹3,078.6416.42%
2028₹3,730.6321.17%
2029₹4,151.7511.28%
2030₹4,579.1310.29%
2031₹4,631.61.14%
2032₹5,089.939.89%
2033₹5,886.2315.64%
2034₹6,302.167.06%
2035₹6,728.286.76%
2036₹6,618.86-1.63%
2037₹7,101.247.28%
2038₹8,041.8213.24%
2039₹8,425.734.77%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Sun Pharma Past Performance

SUNPHARMA main
Sun Pharma has been listed on NSE for more than 29 years.
  • In 1995, Sun Pharma opening price was ₹1.63
  • As of Wed 18 Dec 2024 the price stands at ₹1,801.05.
  • This represents a Compound Annual Growth Rate (CAGR) of 26.31%.
  • In 29 years, an investment of 10,000 would have become ₹1.1 Crore.

As we wrap up, we hope you like our study on Sun Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Sun Pharmaceutical Industries Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter